Altimmune Inc (ALT)

Altimmune (ALT) Financial Statements


Altimmune Financial Overview

Altimmune's market cap is currently ―. The company's EPS TTM is $-1.588; its P/E ratio is -4.16; Altimmune is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 37.00K$ 362.00K$ 6.00K$ 21.00K$ -110.00K
Gross Profit$ 37.00K$ 362.00K$ 6.00K$ 21.00K$ -110.00K
EBIT$ -31.64M$ -20.64M$ -16.06M$ -20.07M$ -23.31M
EBITDA$ -29.75M$ -20.64M$ -16.06M$ -20.07M$ -23.34M
Net Income Common Stockholders$ -31.64M$ -20.67M$ -16.06M$ -20.07M$ -21.66M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 197.81M$ 140.78M$ 160.00M$ 165.76M$ 184.91M
Total Assets$ 210.64M$ 166.57M$ 183.32M$ 187.08M$ 206.93M
Total Debt$ 0.00$ 4.30M$ 4.17M$ 4.40M$ 4.58M
Net Debt$ -197.81M$ -136.47M$ -155.83M$ -161.36M$ -180.33M
Total Liabilities$ 16.54M$ 16.18M$ 15.60M$ 19.35M$ 21.64M
Stockholders Equity$ 194.10M$ 150.40M$ 167.71M$ 167.73M$ 185.29M
Cash Flow-
Free Cash Flow$ -16.53M$ -20.49M$ -19.38M$ -19.46M$ -17.34M
Operating Cash Flow$ -16.53M$ -20.49M$ -19.38M$ -19.41M$ -17.31M
Investing Cash Flow$ -7.96M$ 4.40M$ 3.99M$ 13.30M$ 981.00K
Financing Cash Flow$ 72.75M$ 588.00K$ 13.06M$ -302.00K$ -43.00K
Currency in USD

Altimmune Earnings and Revenue History

Altimmune Debt to Assets

Altimmune Cash Flow

Altimmune Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis